Pretransplant alterations in serum protein glycosylation are associated to risk of hcc recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study
- Author
- Xavier Verhelst (UGent) , Heleen Engels (UGent) , Allison Geerts (UGent) , Aude Vanlander, LUIS ABREU DE CARVALHO (UGent) , Helena Degroote (UGent) , Leander Meuris (UGent) , Frederik Berrevoet (UGent) , Nico Callewaert (UGent) and Hans Van Vlierberghe (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GQMC8CDZDCEHPPQ4PKPQZPG2
- MLA
- Verhelst, Xavier, et al. “Pretransplant Alterations in Serum Protein Glycosylation Are Associated to Risk of Hcc Recurrence after Liver Transplantation and Provide a Potential Prognostic Biomarker : A Proof-of-Concept Study.” TRANSPLANTATION, vol. 106, no. 8S, Supplement 8, 2022, pp. 20–20.
- APA
- Verhelst, X., Engels, H., Geerts, A., Vanlander, A., ABREU DE CARVALHO, L., Degroote, H., … Van Vlierberghe, H. (2022). Pretransplant alterations in serum protein glycosylation are associated to risk of hcc recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study. TRANSPLANTATION, 106(8S, Supplement 8), 20–20.
- Chicago author-date
- Verhelst, Xavier, Heleen Engels, Allison Geerts, Aude Vanlander, LUIS ABREU DE CARVALHO, Helena Degroote, Leander Meuris, Frederik Berrevoet, Nico Callewaert, and Hans Van Vlierberghe. 2022. “Pretransplant Alterations in Serum Protein Glycosylation Are Associated to Risk of Hcc Recurrence after Liver Transplantation and Provide a Potential Prognostic Biomarker : A Proof-of-Concept Study.” In TRANSPLANTATION, 106:20–20.
- Chicago author-date (all authors)
- Verhelst, Xavier, Heleen Engels, Allison Geerts, Aude Vanlander, LUIS ABREU DE CARVALHO, Helena Degroote, Leander Meuris, Frederik Berrevoet, Nico Callewaert, and Hans Van Vlierberghe. 2022. “Pretransplant Alterations in Serum Protein Glycosylation Are Associated to Risk of Hcc Recurrence after Liver Transplantation and Provide a Potential Prognostic Biomarker : A Proof-of-Concept Study.” In TRANSPLANTATION, 106:20–20.
- Vancouver
- 1.Verhelst X, Engels H, Geerts A, Vanlander A, ABREU DE CARVALHO L, Degroote H, et al. Pretransplant alterations in serum protein glycosylation are associated to risk of hcc recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study. In: TRANSPLANTATION. 2022. p. 20–20.
- IEEE
- [1]X. Verhelst et al., “Pretransplant alterations in serum protein glycosylation are associated to risk of hcc recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study,” in TRANSPLANTATION, Istanbul, Turkey, 2022, vol. 106, no. 8S, Supplement 8, pp. 20–20.
@inproceedings{01GQMC8CDZDCEHPPQ4PKPQZPG2,
articleno = {{O-033}},
author = {{Verhelst, Xavier and Engels, Heleen and Geerts, Allison and Vanlander, Aude and ABREU DE CARVALHO, LUIS and Degroote, Helena and Meuris, Leander and Berrevoet, Frederik and Callewaert, Nico and Van Vlierberghe, Hans}},
booktitle = {{TRANSPLANTATION}},
issn = {{0041-1337}},
language = {{eng}},
location = {{Istanbul, Turkey}},
number = {{8S, Supplement 8}},
pages = {{O-033:20--O-033:20}},
title = {{Pretransplant alterations in serum protein glycosylation are associated to risk of hcc recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study}},
volume = {{106}},
year = {{2022}},
}